Loading clinical trials...
Loading clinical trials...
French National Longitudinal Prospective Follow-up of Children Born Small for Gestational Age and Treated With Norditropin SimpleXx (French Health Authorities Commitment)
Conditions
Interventions
somatropin
somatropin
Locations
1
France
Novo Nordisk Investigational Site
Paris La Défense, France
Start Date
March 18, 2007
Primary Completion Date
October 9, 2018
Completion Date
October 9, 2018
Last Updated
October 20, 2022
NCT02769975
NCT06918236
NCT06662045
NCT04720690
NCT05901688
NCT05382637
Lead Sponsor
Novo Nordisk A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions